Mixed
Sarcopenic obesity is a distinct clinical phenotype characterized by high fat mass and low skeletal muscle mass/function, associated with increased risks of frailty, mortality, and metabolic complications, requiring specific diagnostic algorithms (e.g., ESPEN-EASO) for identification.
If you have obesity and are experiencing weakness, fatigue, or functional decline, especially as you age, ask your doctor about sarcopenic obesity. It is not just 'being overweight'; it involves muscle loss which increases health risks. Diagnosis requires specific tests for muscle mass and strength, not just BMI.
Sarcopenic obesity is a likely common, but certainly underestimated obesity phenotype, with an important negative clinical impact... The combination of obesity and low muscle mass and function... is associated with substantial negative impact on clinical outcomes [3&,7&,10–13].
Why this rating
Based on multiple observational studies, consensus guidelines (ESPEN-EASO, GLIS), and meta-analyses cited in the review.
Source
Detecting sarcopenia in obesity: emerging new approaches
G. Gortan Cappellari et al. · Current Opinion in Clinical Nutrition & Metabolic Care · 2024
DOI 10.1097/mco.0000000000001062
More from this paper
- Resistance-based exercise and protein supplementation are the most consistently effective strategies to treat sarcopenic obesity, with combination therapies showing more positive results.Good
- Weight loss interventions (pharmacological or bariatric) in sarcopenic obesity can improve muscle-specific strength and functional parameters despite absolute muscle mass loss, potentially reversing the sarcopenic obesity diagnosis.Moderate
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →